These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2349260)

  • 1. Haloperidol produces within-session increments in operant response duration in rats.
    Liao RM; Fowler SC
    Pharmacol Biochem Behav; 1990 May; 36(1):191-201. PubMed ID: 2349260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol-induced within-session response decrement patterns and catalepsy in rats: behavioural dissociation.
    Drinkenburg WH; Keith AB; Sahgal A; Andrews JS
    Behav Pharmacol; 1999 Feb; 10(1):105-11. PubMed ID: 10780307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of operant response duration to distinguish the effects of haloperidol from nonreward.
    Faustman WO; Fowler SC
    Pharmacol Biochem Behav; 1981 Aug; 15(2):327-9. PubMed ID: 7312904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of haloperidol on the biophysical characteristics of operant responding: implications for motor and reinforcement processes.
    Fowler SC; LaCerra MM; Ettenberg A
    Pharmacol Biochem Behav; 1986 Oct; 25(4):791-6. PubMed ID: 3786339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update of Fowler and Das: anticholinergic reversal of haloperidol-induced, within-session decrements in rats' lapping behavior.
    Das S; Fowler SC
    Pharmacol Biochem Behav; 1996 Apr; 53(4):853-5. PubMed ID: 8801588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of drugs on schedule-controlled behavior in rats during chronic haloperidol administration.
    Rastogi SK; McMillan DE
    J Pharmacol Exp Ther; 1985 Feb; 232(2):295-300. PubMed ID: 3968634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol blocks the response-reinstating effects of food reward: a methodology for separating neuroleptic effects on reinforcement and motor processes.
    Horvitz JC; Ettenberg A
    Pharmacol Biochem Behav; 1988 Dec; 31(4):861-5. PubMed ID: 3252277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of chronic haloperidol and clozapine upon operant rate and duration.
    Faustman W; Fowler S; Walker C
    Eur J Pharmacol; 1981 Mar; 70(1):65-70. PubMed ID: 7215441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-haloperidol discrimination: effects of chronic drug treatment.
    Haenlein M; Caul WF; Barrett RJ
    Pharmacol Biochem Behav; 1985 Dec; 23(6):949-52. PubMed ID: 4080781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of corticotropin releasing factor, desipramine and haloperidol on a DRL schedule of reinforcement.
    Britton KT; Koob GF
    Pharmacol Biochem Behav; 1989 Apr; 32(4):967-70. PubMed ID: 2798545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different patterns of behavior produced by haloperidol, pentobarbital, and dantrolene in tests of unconditioned locomotion and operant responding.
    Hammond EO; Torok ML; Ettenberg A
    Psychopharmacology (Berl); 1991; 104(2):150-6. PubMed ID: 1876659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antipsychotic drugs on operant responding after acute and repeated administration.
    Varvel SA; Vann RE; Wise LE; Philibin SD; Porter JH
    Psychopharmacology (Berl); 2002 Mar; 160(2):182-91. PubMed ID: 11875636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The actions of SCH 23390, a D1 receptor antagonist, on operant and avoidance behavior in rats.
    Sanger DJ
    Pharmacol Biochem Behav; 1987 Mar; 26(3):509-13. PubMed ID: 3554270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic haloperidol treatment: effects on operant responding and inter-response time.
    Heath GF; Rech RH
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):697-701. PubMed ID: 4089193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of chronic effects of diazepam on responding of rats under fixed-ratio schedules.
    Smith JB
    Eur J Pharmacol; 1999 Dec; 385(2-3):89-97. PubMed ID: 10607863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats.
    Sanger DJ; Perrault G
    J Pharmacol Exp Ther; 1995 Feb; 272(2):708-13. PubMed ID: 7531764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic effects of haloperidol and SCH23390 on operant and licking behaviors in the rat.
    Liao RM; Ko MC
    Chin J Physiol; 1995; 38(2):65-73. PubMed ID: 8697900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral deficits induced by low doses of apomorphine in rats: evidence for a motivational and cognitive dysfunction which discriminates among neuroleptic drugs.
    Carnoy P; Ravard S; Wemerman B; Soubrie P; Simon P
    Pharmacol Biochem Behav; 1986 Sep; 25(3):503-9. PubMed ID: 2877466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing between haloperidol's and decamethonium's disruptive effects on operant behavior in rats: use of measurements that complement response rate.
    Fowler SC; Skjoldager PD; Liao RM; Chase JM; Johnson JS
    J Exp Anal Behav; 1991 Sep; 56(2):239-60. PubMed ID: 1955815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing.
    Farrar AM; Pereira M; Velasco F; Hockemeyer J; Müller CE; Salamone JD
    Psychopharmacology (Berl); 2007 Apr; 191(3):579-86. PubMed ID: 17072593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.